BiotechTube
Home/Vertero Therapeutics/Becca Senter, PhD
BS

Becca Senter, PhD

Chief Scientific Officer

Vertero Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's Disease

Vertero Therapeutics Pipeline

DrugIndicationPhase
VT-5006Parkinson's DiseasePre-clinical

Leadership Team at Vertero Therapeutics

AS
A. Stewart Campbell, PhD
Chief Executive Officer
JK
Jeffrey Kasten
Chief Business Officer
View full Vertero Therapeutics profile